190 related articles for article (PubMed ID: 28256371)
1. Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects.
Fares M; Eladwy RA; Nocentini A; El Hadi SRA; Ghabbour HA; Abdel-Megeed A; Eldehna WM; Abdel-Aziz HA; Supuran CT
Bioorg Med Chem; 2017 Apr; 25(7):2210-2217. PubMed ID: 28256371
[TBL] [Abstract][Full Text] [Related]
2. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors.
Akocak S; Lolak N; Bua S; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1575-1580. PubMed ID: 30296852
[TBL] [Abstract][Full Text] [Related]
4. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT
Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
Cecchi A; Ciani L; Winum JY; Montero JL; Scozzafava A; Ristori S; Supuran CT
Bioorg Med Chem Lett; 2008 Jun; 18(12):3475-80. PubMed ID: 18513964
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
10. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors.
Abdel-Aziz AA; Angeli A; El-Azab AS; Abu El-Enin MA; Supuran CT
Bioorg Med Chem; 2017 Mar; 25(5):1666-1671. PubMed ID: 28161252
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds.
Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009
[TBL] [Abstract][Full Text] [Related]
16. Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity.
Bozdag M; Alafeefy AM; Vullo D; Carta F; Dedeoglu N; Al-Tamimi AM; Al-Jaber NA; Scozzafava A; Supuran CT
Bioorg Med Chem; 2015 Dec; 23(24):7751-64. PubMed ID: 26639945
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
18. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors.
Ceruso M; Antel S; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(2):205-11. PubMed ID: 25792500
[TBL] [Abstract][Full Text] [Related]
20. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
